manufacturing potentially life-changing biosimilars for patients during covid-19
Published 4 years ago • 1.2K plays • Length 3:49Download video MP4
Download video MP3
Similar videos
-
1:52
biosimilars increase access to life changing treatments
-
51:33
unlocking the potential of biosimilars worldwide - panel 2
-
1:21
biologics revolutionized healthcare
-
0:44
sandoz’ commitment to patients
-
2:57
15 years after the approval and launch of the world’s first biosimilar, where are we now?
-
1:22
what’s so great about biosimilars?
-
7:18
perspectives on access, biosimilars and generics
-
2:52
how biologic medicines are made | how it's made
-
7:25
novartis ceo: setting up sandoz for next wave of growth
-
6:23
sandoz will be a long-term stable business if it can get its cost structure right, novasecta says
-
44:08
15-years of biosimilars in europe: what lessons can we share? - panel 1
-
38:15
biosimilars and biologics
-
56:39
cadth webinar — biologics and biosimilars
-
2:35
15 years of biosimilars – timeline
-
0:57
how do you ensure biologics and biosimilars are the same?
-
4:46
biosimilars and sandoz
-
0:31
biosimilars benefit patients, doctors and healthcare systems
-
1:31:06
biologics & biosimilars: insights for patients & physicians
-
51:49
virtual innovation classroom: what is a biosimilar?
-
15:01
euronews debates highlights | how can europe shape the future of biosimilar medicines?
-
1:14
how biosimilars are building momentum in the us